Navigation Links
Immucor Announces Fiscal Fourth Quarter Results
Date:7/23/2009

han 600 orders, which represents approximately 10% of our estimated addressable worldwide market," stated Dr. De Chirico.

"We expect to launch our next generation Galileo instrument, the Galileo Neo(TM), in early 2010. Targeted at high volume customers, the Galileo Neo is our fourth generation automated instrument," stated Dr. De Chirico. "We have the newest instrumentation on the market and believe that both Immucor and our customers benefit from our automation strategy."

Fiscal 2010 Guidance

The Company continues to expect fiscal 2010 consolidated revenue in the range of $322 million to $332 million and consolidated gross margins in the range of 70.0% to 71.5%. The Company's Quality Process Improvement Project is included in cost of goods sold. The Company continues to expect expenses related to the project in fiscal 2010 to be in the range of $4.0 million to $4.5 million.

The Company continues to expect diluted earnings per share to be in the range of $1.10 to $1.17 for fiscal 2010, which includes the approximately $0.04 per share impact, net of tax, related to the Quality Process Improvement Project. The Company's fiscal 2010 guidance also includes a full year of BioArray expenses. BioArray was acquired on August 4, 2008.

"We believe in our opportunities for long-term sustainable growth and will continue to focus on the business to produce results that provide returns for both our customers and our shareholders," stated Dr. De Chirico.

Conference Call

Immucor, Inc. will host a conference call Friday, July 24, 2009 at 8:30 AM (Eastern Time) to review these results. To participate in the telephone conference call, dial 1-888-324-9321 (Passcode: BLUD). The Company will also provide a live audio broadcast of the call via webcast. The webcast can be accessed at www.immucor.com in the "About Us - Investor Information" section b
'/>"/>

SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Immucor Appoints Chief Operating Officer
2. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
3. Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009
4. Immucor Announces Fiscal Year 2010 Guidance
5. Immucor to Announce Fiscal 2010 Guidance on Monday, June 1, 2009
6. Immucor to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
7. Immucor Receives Subpoena From Department of Justice
8. Immucor Announces Fiscal Third Quarter Results
9. Immucor Announces New Vice President, Operations
10. Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
11. Immucor Closes BioArray Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Wellesley, Mass., September 23, 2014 – ... report, Joint Reconstruction and Replacement: Materials, Technologies, ... reconstruction and replacement is expected to increase to nearly ... rate (CAGR) of 4.2% from 2013 through 2018. The ... surging at a CAGR of 5.1%. , Revision and ...
(Date:9/23/2014)... 23, 2014 The print component of ... Metro, with a circulation of approximately 327,720 copies and ... distributed nationally through a vast social media strategy and ... outlets. To explore the digital version of the campaign, ... exclusive interview with Michael Landsberg, host of TSN’s Off ...
(Date:9/23/2014)... awarded $10.1 million in supplemental funding to bolster the ... sex in preclinical and clinical studies. , This investment ... a catalyst for considering sex as a fundamental variable ... preclinical research can obscure key findings related to sex ... will result in greater awareness of the need to ...
(Date:9/23/2014)... September 23, 2014 With summer at ... in spirit and weather), organic food manufacturing company Earth ... month centered on sweet treats for the whole family. ... bite-sized candies by the handful in celebration of the ... recent years these festivities come with an increasing degree ...
(Date:9/23/2014)... 2014 The U.S. Pharmacopeial Convention (USP) ... Health Organization (WHO) regarding the assignment of Biological Qualifiers ... by the Expert Group of the Programme of International ... to the naming of all biologicals that is consistent ... assessment of these drugs. , Hence, USP supports ...
Breaking Medicine News(10 mins):Health News:Global Market for Joint Reconstruction and Replacement to reach $16.2 Billion in 2018; The U.S. Market Moving at 5.1% CAGR 2Health News:Global Market for Joint Reconstruction and Replacement to reach $16.2 Billion in 2018; The U.S. Market Moving at 5.1% CAGR 3Health News:‘Sick, not weak’: Mediaplanet’s "Mental Health” Campaign Dispels Stigmas and Bolsters Support for the One in Five Canadians Suffering Mental Illness 2Health News:New supplemental awards apply sex and gender lens to NIH-funded research 2Health News:New supplemental awards apply sex and gender lens to NIH-funded research 3Health News:Righteously Raw Chocolates Promote Healthy, Fun Snacking this Fall Season 2Health News:USP Comments to WHO Regarding Biologics Qualifier Proposal 2
... organizations that address health care ... access and priorities in a four-state region, PORTLAND, ... insurer in the Northwest/ Intermountain region, announced today the,launch ... in,the United States. The Regence Foundation estimates it will ...
... Northwest Hospital &,Medical Center announced today that it will ... 2008 KING 5 Healthy Living Expo, from 10 a.m.,- ... 20, at the Qwest Field,Exhibition Center West Hall., ... expected attendance,of more than 44,000 people. Admission is free., ...
... April 14 U.S. Environmental,Protection Agency Region 5 ... alleged clean-air violations at the company,s coal preparation,plant ... Beallsville, Ohio., The agreement, which includes a ... comply with testing, notification and,reporting requirements at the ...
... can cause an aggressive,form of acute lymphoblastic leukemia ... April 14 Researchers at St.,Jude Children,s Research ... mutations work together to initiate most cases of ... (ALL)., These defects, known as "cooperating oncogenic ...
... CCA Industries, Inc.,(Amex: CAW ) announced today ... share fully diluted of $0.05 for the first,quarter ended ... year,were $13,975,385, and net income was $472,753, with fully ... net income has always been the lowest quarter,because the ...
... petinsurance.com, BREA, Calif., April 14 Veterinary ... of pet health insurance, has,designated the last Sunday ... as National,Pet Parent,s Day, slating the nation,s first ... of a spring season set aside for,celebrating parents ...
Cached Medicine News:Health News:Newly Launched Regence Foundation to Help Transform Health Care and Influence the Nationwide Health Care Debate 2Health News:Northwest Hospital & Medical Center Hosts Health & Wellness Pavilion At Second Annual King 5 Healthy Living Expo 2Health News:St. Jude Discovery Offers New Avenues to Understanding an Aggressive Form of Leukemia 2Health News:St. Jude Discovery Offers New Avenues to Understanding an Aggressive Form of Leukemia 3Health News:CCA Industries, Inc. Announces First Quarter Results 2Health News:Veterinary Pet Insurance Launches National Pet Parent's Day 2
(Date:9/23/2014)... BERGEN, Norway , September 23, 2014 /PRNewswire/ ... "Company"), an oncology biopharmaceutical company, today announces it ... million) Seeding Drug Discovery Award from the UK,s ... against BGB002, its proprietary, novel cancer target. ... are to identify and fund especially promising, innovative ...
(Date:9/23/2014)... , Sept. 23, 2014  As physicians ... to digital communication channels to learn about new ... finding – from a new report by global ... – shows that communicating via a customized mix ... provides the best opportunity to engage with physicians. ...
(Date:9/23/2014)... , Sept. 23, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... additions to its Scientific Advisory Board.  The new members ... Davies , PhD. Dr. Acker is a ...
Breaking Medicine Technology:BerGenBio Granted a Prestigious Wellcome Trust Seeding Drug Discovery Award 2BerGenBio Granted a Prestigious Wellcome Trust Seeding Drug Discovery Award 3As sales reps see doors close for in-person visits with physicians, digital doors open communication 2As sales reps see doors close for in-person visits with physicians, digital doors open communication 3As sales reps see doors close for in-person visits with physicians, digital doors open communication 4As sales reps see doors close for in-person visits with physicians, digital doors open communication 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7
... Harco Metal Products (Harco), an industry leader in tube fabrication, systems ... manufacture MediGLIDER™ products for ConMediSys. , ... ConMediSys, the developer of safety products for health ... cost associated with staff injuries caused by physically lifting and moving ...
... 23 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... 26, 2010 , at 8:00 a.m. Eastern Time ( 5:00 ... , , ... live webcast of the presentation on the company,s website at: http://www.onyx-pharm.com/view.cfm/32/Event-Calendar ...
Cached Medicine Technology:Harco Partners With ConMediSys to Deliver Patient Safety and Equipment Integrity 2Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide a Clinical Update on Carfilzomib 2
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
Antibiotics (Gentamicin) loaded, low viscosity bone cement for syringe use with an average setting time of approx. 7-9 Min., 41.6g of powder and 16.4g of liquid....
... Featuring new technology, such as a recessed ... and lens housings, this arthroscope has superior ... by EO, Steris and steam autoclaving or ... Light post/adapters to fit ACMI, Wolf, Dyonics ...
... Passport II delivery device is the second ... C11UB. Its simple-to-use syringe technology allows one-handed ... small incision. The blue colored plunger allows ... protect the haptics during insertion. The modified ...
Medicine Products: